Skip to Main Content

Paper Details

The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
medRxiv
92
2021
Author NameAffiliation
Chengjin YeTexas Biomedical Research Institute
Raveen RathnasingheIcahn School of Medicine at Mount Sinai New York
Raveen RathnasingheGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York
Raveen RathnasingheIcahn School of Medicine at Mount Sinai
Viviana SimonIcahn School of Medicine at Mount Sinai New York
Viviana SimonGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York
Viviana SimonIcahn School of Medicine at Mount Sinai New York
Luis Martinez-SobridoTexas Biomedical Research Institute
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai New York
Adolfo Garc??a-SastreGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai New York
Adolfo Garc??a-SastreThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai New York
Michael SchotsaertIcahn School of Medicine at Mount Sinai New York
Michael SchotsaertGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York
  • 1 - 14

Datasets

Release 1.2